Synthetic oxepanoprolinamide iboxamycin is highly active against human pathogen <i>Listeria monocytogenes</i>

Tetiana Brodiazhenko(University of Tartu), Vasili Hauryliuk(Lund University), Ben I.C. Tresco(Harvard University), Hiraku Takada(Kyoto Sangyo University), Kathryn Jane Turnbull(Rigshospitalet), Tanel Tenson(University of Tartu), Andrew G. Myers(Harvard University), Kelvin J. Y. Wu(Harvard University)
bioRxiv (Cold Spring Harbor Laboratory)
February 28, 2022
Cited by 0


Related Papers